D. E. Shaw & Co., Inc. Clear Point Neuro, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 79,031 shares of CLPT stock, worth $884,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,031
Previous 41,615
89.91%
Holding current value
$884,356
Previous $282,000
50.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.04MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$13.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.21 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA463KShares$5.18 Million0.49% of portfolio
-
Taylor Frigon Capital Management LLC425KShares$4.75 Million1.1% of portfolio
-
Cm Management, LLC375KShares$4.2 Million1.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $274M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...